Stahl Online is a one-stop shop, covering everything a mental health professional or teacher will ever need to know about neuropsychopharmacology. Comprehensive and regularly updated, Stahl Online provides full access to the entire current portfolio of books by Dr Stephen M. Stahl.
Stahl Online is a one-stop shop, covering everything a mental health professional or teacher will ever need to know about neuropsychopharmacology. Comprehensive and regularly updated, Stahl Online provides full access to the entire current portfolio of books by Dr Stephen M. Stahl.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Edited by
Nevena V. Radonjić, State University of New York Upstate Medical University,Thomas L. Schwartz, State University of New York Upstate Medical University,Stephen M. Stahl, University of California, San Diego
If we had to pick the single most important factor that goes into clinical decision-making in psychiatry, it would not be anything related to pharmacology, psychotherapy, genetics, Maudsley staging scores, or any other kinds of historical illness characteristics, but rather, it would be determining the appropriate level of care needed for a given individual patient. Why is that, given the many breakthroughs in neuroscience and our understanding of psychopharmacology? Nobel prizes have been awarded for elucidating the intricacies of second messenger signal transduction in neurons, but not for the intricacies of deducing the merits of an intensive outpatient program versus a partial hospital program. Or for knowing when a multidisciplinary “team” approach is wiser than being seen by an individual practitioner. For all the attention heaped upon presumptive brain mechanisms of psychopathology and the impact of evidence-based treatments thought to modulate brain dysfunction, one cannot escape the psychosocial context in which most mental health conditions arise. Chronic and recurrent mental health conditions often spill into people’s daily lives in ways that can be tumultuous, volatile, and precarious. Coping with distress and adversity often can become a primary goal of treatment, and for some difficult-to-treat psychiatric conditions, questing for a medicine to eradicate chronic symptoms may sometimes need relegation to a secondary rather than primary objective. Many treatments in psychiatry are more disease-managing than disease-modifying (meaning, they may lessen the adverse impact of psychiatric symptoms but not necessarily eradicate or prevent them).
Edited by
Nevena V. Radonjić, State University of New York Upstate Medical University,Thomas L. Schwartz, State University of New York Upstate Medical University,Stephen M. Stahl, University of California, San Diego
Edited by
Nevena V. Radonjić, State University of New York Upstate Medical University,Thomas L. Schwartz, State University of New York Upstate Medical University,Stephen M. Stahl, University of California, San Diego
Edited by
Nevena V. Radonjić, State University of New York Upstate Medical University,Thomas L. Schwartz, State University of New York Upstate Medical University,Stephen M. Stahl, University of California, San Diego
Edited by
Nevena V. Radonjić, State University of New York Upstate Medical University,Thomas L. Schwartz, State University of New York Upstate Medical University,Stephen M. Stahl, University of California, San Diego
Thus far we have discussed how clinicians are the primary if not sole evaluators and decision-makers when it comes to devising treatment recommendations. Shared decision-making (SDM) is a not-so-new but increasingly recognized form of patient-centered care in which a patient and their clinician actively collaborate to determine which treatment options are most consistent with the patient’s own values, priorities and goals. As described originally by Charles et al. (1997) and later expanded on by Elwyn et al. (2012), an SDM model first involves introducing choice followed by describing options (sometimes using patient decision-support tools – such as charts, graphs, brochures, interactive websites, or audiovisual materials) followed by helping patients explore their preferences in order to make the best decisions for them. Greater focus is placed on the patient’s own narrative and personal experience as influencing treatment decisions, rather than on general diagnostic issues or outcomes.
